Psychiatric News (11/23) reports, “Prazosin is effective at reducing alcohol consumption in adults with alcohol use disorder (AUD) and severe withdrawal symptoms such as sweating, headache, and nausea,” investigators concluded in a “12-week, randomized clinical trial of 112 treatment-seeking adults with AUD.” The study revealed that “those with severe withdrawal symptoms who took prazosin had half as many drinking days and only one-fifth the number of heavy drinking days as adults with severe withdrawal symptoms taking placebo.” The findings were published online Nov. 19 in the American Journal of Psychiatry, a publication of the American Psychiatric Association.
Related Links:
— “Prazosin Can Reduce Drinking in AUD Patients With Severe Withdrawal Symptoms, Psychiatric News, November 23, 2020